The IMF has urged South Africa (SA) to ensure it tightly monitors supply chain risks at Africa’s biggest Covid-19 vaccine manufacturing facility.
Aspen Pharmacare in SA is expected to produce nearly a third of the African Union’s vaccine requirements after the AU signed a deal with Johnson & Johnson for 220m single-shot doses.
☛ Want to stay up to date with the news? Sign up to our daily bulletin.
Receive email job alerts from Supply Management Jobs click here >
Not a CIPS member? Why not join CIPS to access a full range of benefits, including:
And much more.
Click here to join >